These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7219791)

  • 21. [Evaluation of cefroxadine in the field of pediatrics (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Inokuma K; Nakamura H
    Jpn J Antibiot; 1981 Dec; 34(12):1663-79. PubMed ID: 7334591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cefroxadine].
    Mashimo K
    Jpn J Antibiot; 1982 Jun; 35(6):1365-73. PubMed ID: 6752462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of cefroxadine in bacterial infections of the eye].
    Ooishi M; Nagai S; Nishizuka K; Tanaka R; Takagi K; Hara J; Tanaka Y; Ichihashi K; Hirose Y; Akashi N
    Jpn J Antibiot; 1983 Sep; 36(9):2635-64. PubMed ID: 6655872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activity of oral cefroxadin (Oraspor) in childhood infections. Multicentric study of 123 patients].
    Bonzano L; Borghi C; Calvani M; Miotti AM; Nicola P; Urbino A; Pedrinazzi RC; Principi N; Onorato J; Spada A
    Minerva Pediatr; 1987 Jan; 39(1-2):79-83. PubMed ID: 3600563
    [No Abstract]   [Full Text] [Related]  

  • 25. [A new oral cephalosporin in the therapy of acute bacterial bronchopneumopathy].
    Squadrini F; Vaccari F; De Rienzo B; Zanchetta G; Taparelli F; Lami G; Mongiardo N
    Clin Ter; 1982 Oct; 103(2):139-50. PubMed ID: 7151376
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental and clinical evaluation of cefroxadine in the field of obstetrics and gynecology].
    Cho N; Araki H; Ishikawa T; Kunii K; Fukunaga K; Deguchi K
    Jpn J Antibiot; 1983 Sep; 36(9):2535-48. PubMed ID: 6655868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical effect and transfer into the wound exudate of cefroxadine used in the treatment of soft tissue infection].
    Takata N; Yamada T; Kubota T; Kaneko T
    Jpn J Antibiot; 1983 Sep; 36(9):2529-34. PubMed ID: 6655867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of a new cephalosporin for oral use in dermatology].
    Goitre M; Bedello PG
    G Ital Dermatol Venereol; 1982; 117(4):XLIX-LIV. PubMed ID: 6764911
    [No Abstract]   [Full Text] [Related]  

  • 29. Cefroxadine in the treatment of children affected by respiratory and ENT diseases. A multicentre study involving 1072 in-patients.
    Scaglione F; Cattaneo G; Bianchi MM; Verdecchia P; Maresca V; Bichisao E; Fraschini F
    Drugs Exp Clin Res; 1989; 15(2):71-6. PubMed ID: 2737082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of cefroxadine dry syrup in pediatric field (author's transl)].
    Minamitani M; Hachimori K; Suzuki M; Minamikawa I
    Jpn J Antibiot; 1981 Dec; 34(12):1626-33. PubMed ID: 7334587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A clinical study on cefroxadine in the treatment and recurrence of acute uncomplicated cystitis].
    Kumon H; Ohmori H
    Jpn J Antibiot; 1987 Apr; 40(4):703-10. PubMed ID: 3613088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Laboratory and clinical studies of cefroxadine (author's transl)].
    Nishimura T; Tabuki K; Hiromatsu K; Takashima T; Kotani Y
    Jpn J Antibiot; 1981 Dec; 34(12):1634-46. PubMed ID: 7334588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of cefroxadine in pediatrics regarding clinical efficacy and serum levels (author's transl)].
    Iwasaki Y; Iwata S; Kanemitsu T; Jozaki K; Hattori H; Akita H; Hotta M; Yamashita N; Nanri S; Sunakawa K; Oikawa T; Osano M; Ichihashi Y; Kuratsuji T; Haginiwa Y
    Jpn J Antibiot; 1981 Dec; 34(12):1595-603. PubMed ID: 7334584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CGP 9000: a new orally active, broad-spectrum cephalosporin.
    Zak O; Vischer WA; Schenk C; Tosch W; Zimmermann W; Regös J; Suter ER; Kradolfer F; Gelzer J
    J Antibiot (Tokyo); 1976 Jun; 29(6):653-5. PubMed ID: 950320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cefroxadine and cephalexin in urinary tract infections. Kinetics of germ elimination].
    Naber KG; Ahrens T
    Fortschr Med; 1982 Oct; 100(39):1827-31. PubMed ID: 6759334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twice daily treatment of pneumonia with cephradine.
    Caloza DL; Bernfeld GE
    J Maine Med Assoc; 1977 May; 68(5):152-5. PubMed ID: 325160
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of cefroxadine dry syrup in the management of acute skin infections in children (author's transl)].
    Arata J; Yamamoto Y; Hagiyama M; Nohara N; Suwaki M; Miyoshi K; Masuda T; Nakagawa S; Ueki H; Nakakita T; Kashiwa N; Tokumaru S; Arakawa K; Take M; Nishihara O; Masuda T; Hiramatsu H; Yamada M; Nishimoto M; Tada J; Umemura S; Fujimoto W; Tanaka A; Okuma N
    Jpn J Antibiot; 1981 Dec; 34(12):1748-64. PubMed ID: 7038191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and laboratory evaluation of the effect of cephradine on patients with ear, nose and throat infections.
    Malmborg AS; Meder B; Wersäll J
    Chemotherapy; 1975; 21(5):311-7. PubMed ID: 1157576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized double-blind investigation of cefroxadine (CGP 9000) versus cephalexin in urinary tract infection.
    Hess J; Gammelgaard P; Holst B; Rasmussen F; Thomsen VF
    Infection; 1984; 12(4):270-3. PubMed ID: 6436182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of a new cephalosporin, CGP 9000 (cefroxadine), in healthy volunteers.
    Bergan T
    Chemotherapy; 1980; 26(4):225-30. PubMed ID: 7389422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.